Filing Details
- Accession Number:
- 0001110803-10-000252
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-23 19:54:34
- Reporting Period:
- 2010-12-21
- Filing Date:
- 2010-12-23
- Accepted Time:
- 2010-12-23 19:54:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263805 | O Christian Henry | 9885 Towne Centre Drive San Diego CA 92121-1975 | Sr Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-21 | 4,900 | $10.49 | 30,972 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-21 | 4,900 | $64.30 | 26,072 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-12-21 | 100 | $10.49 | 26,172 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-21 | 100 | $65.12 | 26,072 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-12-21 | 5,000 | $0.00 | 5,000 | $10.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,167 | 2006-02-28 | 2016-01-30 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 4,900 shares sold ranging from $63.97 to $64.96 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 100 shares sold ranging from $65.115 to $65.12 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
